Liminal BioSciences Inc. announced the addition of Moira Daniels as the new Head of Regulatory Affairs and Quality Assurance, to its senior leadership team. Moira is a senior regulatory affairs professional with over 30 years of global experience in managing ambitious product development timelines at major pharmaceutical companies, including Astra Zeneca, Pfizer and Eli Lilly. Most recently, she served as VP, Head of Global Regulatory Operations for UCB Pharma based in Brussels, Belgium. Previously, she also worked with PAREXEL, a major CRO, and the USAID project, World Health Organisation.